Skip to main content
. 2015 Jul 31;42(7):845–854. doi: 10.1111/apt.13334

Figure 2.

Figure 2

Relationship between reduction in RDQ dimension scores and participants’ overall rating of their response to treatment (OTE Question 1). Results shown are for participants who reported improvement in symptoms (OTE Question 1). ‘G’ and ‘P’ denote the mean RDQ score change from baseline for the Gaviscon DA and Placebo groups, respectively. GERD, gastroesophageal reflux disease; OTE, overall treatment evaluation; DA, Double Action.